The Link Between Periodontitis, Smoking and Oral Cancer
Launched by CAIRO UNIVERSITY · Aug 3, 2019
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the connection between gum disease (called periodontitis), smoking, and oral cancer. Researchers want to understand how smoking may increase the risk of both gum disease and oral cancer, as well as how having gum disease might raise the risk of developing oral cancer. This is important because gum disease can lead to tooth loss, difficulties with eating, and a decline in overall health, affecting a person's quality of life.
To participate in this trial, individuals must be at least 18 years old and generally healthy. However, people with certain health conditions, pregnant women, and those currently undergoing treatments for oral cancer or other serious diseases will not be eligible. While the trial is not yet recruiting participants, those who join can expect to contribute valuable information that may help improve understanding and treatment of these serious health issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients 18 years or older.
- Exclusion Criteria:
- • Patients with any systemic diseases.
- • Pregnant females.
- • Handicapped and mentally retarded patients.
- • Patients undergoing radiotherapy.
- • Patients having oral cancer
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials